Abstract
The term ‘acute-on-chronic liver failure’ was first used in the 1960s mainly in relation to flares of viral hepatitis. It was not until the turn of the millennium, however, that the term entered the everyday vocabulary of hepatologists when it was used to describe the pathophysiological deterioration in patients with cirrhosis mainly in the context of trials utilizing liver support devices [1]. Since then, a consensus definition of acute-on-chronic liver failure has been fiercely debated. The terms ‘compensated’ and ‘decompensated’ liver disease are rarely used in the critical care arena with patients being defined with regard to the degree of organ dysfunction rather than by quantifying liver synthetic function per se. Moreover, it has been shown that the prognosis in patients with cirrhosis is strongly correlated with the number of failing organs [2–4] and that certain cohorts of patients with severe hepatic encephalopathy, acute variceal bleeding, and organ failure benefit from admission to a critical care environment [5].
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
Keywords
- Liver Failure
- Portal Hypertension
- Hepatic Encephalopathy
- Systemic Inflammatory Response Syndrome
- Sequential Organ Failure Assessment
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Sen S, Davies NA, Mookerjee RP, et al (2004) Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study. Liver Transpl 10: 1109–1119
Gildea TR, Cook WC, Nelson DR, et al (2004) Predictors of long-term mortality in patients with cirrhosis of the liver admitted to a medical ICU. Chest 126: 1598–1603
Cholongitas E, Senzolo M, Patch D, et al (2006) Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit. Aliment Pharmacol Ther 23: 883–893
Zimmerman JE, Wagner DP, Seneff MG, Becker RB, Sun X, Knaus WA (1996) Intensive care unit admissions with cirrhosis: risk-stratifying patient groups and predicting individual survival. Hepatology 23: 1393–1401
Shawcross D, Austin M, Abeles R, et al (2008) Defining the impact of organ dysfunction in cirrhosis: survival at a cost? Gut 57 (Suppl 1):A12–A13 (abst)
Levy M, Fink M, Marshall J, et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 29: 530–538
Rivers E, Nguyen B, Havastad S, et al (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345: 1368–1377
Knaus W, Draper E, Wagner D, Zimmerman J (1985) Prognosis in acute organ-system failure. Ann Surg 202: 685–693
Vincent JL, Moreno R, Takala J, et al (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 22: 707–710
Austin M, Shawcross D (2008) Outcome of patients with cirrhosis admitted to intensive care. Curr Opin Crit Care 14: 202–207
Pugh R, Murray-Lyon I, Dawson J, Pietroni M, Williams R (1973) Transection of the oesophagus for bleeding oesphageal varices. Br J Surg 60: 646–649
Kamath K, Weisner R, Malinchoc M, et al (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33: 464–470
Jenq C, Tsai M, Tain Y, et al (2007) RIFLE classification can predict short-term prognosis in critically ill cirrhotic patients. Intensive Care Med 33: 1921–1930
Wasmuth H, Kunz D, Yagmur E, et al (2005) Patients with acute on chronic liver failure display’ sepsis-like’ immune paralysis. J Hepatol 42: 195–201
Wong F, Bernardi M, Balk R, et al (2005) Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut 54: 718–725
Antoniades CG, Berry PA, Davies ET, et al (2006) Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure. Hepatology 44: 34–43
Jalan R, Newby DE, Damink SW, Redhead DN, Hayes PC, Lee A (2001) Acute changes in cerebral blood flow and metabolism during portasystemic shunting. Liver Transpl 7: 274–278
Van der Linden P, Le Moine O, Ghysels M, Ortinez M, Deviere J (1996) Pulmonary hypertension after transjugular intrahepatic portosystemic shunt: effects on right ventricular function. Hepatology 23: 982–987
Harry R, Auzinger G, Wendon J (2002) The clinical importance of adrenal insufficiency in acute hepatic dysfunction. Hepatology 36: 395–402
Marik P, Gayowski T, Starzl T (2005) The hepatoadrenal syndrome: a common yet unrecognised clinical condition. Crit Care Med 33: 1254–1259
Fernandez J, Escorsell A, Zabalza M, et al (2006) Adrenal insufficiency in patients with cirrhosis and septic shock: Effect of treatment with hydrocortisone on survival. Hepatology 44: 1288–1295
Ferenci P, Lockwood A, Mullen K, et al (2002) Hepatic Encephalopathy — Definition, nomenclature, diagnosis and quantification: Final report of the Working Party at the 11th World Congress of Gastroenterology, Vienna, 1998. Hepatology 35: 716–721
Cordoba J, Alonso J, Rovira A, et al (2001) The development of low-grade cerebral oedema in cirrhosis is supported by the evolution of 1H-magnetic resonance abnormalities after liver transplantation. J Hepatol 35: 598–604
Als-Nielsen B, Gluud L, Gluud C (2004)Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials. BMJ 328: 1046–1050
Cordoba J, Lopez-Hellin J, Planas M, et al (2004) Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. J Hepatol 41: 38–43
Rolando N, Wade J, Davalos M, Wendon J, Philpott-Howard J, Williams R (2000) The systemic inflammatory response syndrome in acute liver failure. Hepatology 32: 734–739
Shawcross D, Davies N, Williams R, Jalan R (2004) Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol 40: 247–254
Liu Q, Duan ZP, Ha dK, Bengmark S, Kurtovic J, Riordan SM (2004) Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 39: 1441–1449
Hassanein T, Tofteng F, Brown R, et al (2007) Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology 46: 1853–1862
Bernal W, Auzinger G, Sizer E, Wendon J (2008) Intensive care management for acute liver failure. Semin Liver Dis 28: 188–200
Chau T, Chan Y, Patch D, Tokanuga S, Greenslade L, Burroughs A (1998) Thrombelastographic changes and early rebleeding in cirrhotic patients with variceal bleeding. Gut 43: 267–271
Papatheodoridis G, Patch D, Webster G, Brooker J, Barnes E, Burroughs A (1999) Infection and hemostasis in decompensated cirrhosis: a prospective study using thrombelastography. Hepatology 29: 1085–1090
Fernandez-Seara J, Prieto J, Quiroga J, et al (1989) Systemic and regional haemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure. Gastroenterology 97: 1304–1312
Moller S, Henriksen J (2008) Cardiovascular complications of cirrhosis. Gut 57: 268–278
Russell J, Walley K, Singer J, et al (2008) Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358: 877–887
Annane D, Sebille V, Charpentier C, et al (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288: 862–871
Malbrain M, Chiumello D, Pelosi P, et al (2004) Prevalence of intra-abdominal hypertension in critically ill patients: a multicentre epidemiological study. Intensive Care Med 30: 822–829
Rajkovic IA, Williams R (1986) Abnormalities of neutrophil phagocytosis, intracellular killing and metabolic activity in alcoholic cirrhosis and hepatitis. Hepatology 6: 252–262
Trevisani F, Castelli E, Foschi FG, et al (2002) Impaired tuftsin activity in cirrhosis: relationship with splenic function and clinical outcome. Gut 50: 707–712
Mookerjee R, Stadlbauer V, Lidder S, et al (2007) Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts outcome. Hepatology 46: 831–840
Shawcross D, Wright G, Stadlbauer V, et al (2008) Ammonia impairs neutrophil phagocytic function in liver disease. Hepatology 48: 1202–1212
Borroni G, Maggi A, Sangiovanni A, Cazzaniga M, Salerno F (2000) Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients. Dig Liver Dis 32: 605–610
Olde Damink S, Jalan R, Deutz N, et al (2003) The kidney plays a major role in the hyperammonemia seen after a simulated or actual upper gastrointestinal bleeding in patients with cirrhosis. Hepatology 37: 1277–1285
Walker S, Stiehl A, Raedsch R, Kommerell B (1986) Terlipressin in bleeding oesphageal varices: a placebo-controlled, double blind study. Hepatology 6: 112–115
Monescillo A, Martinez-Lagares F, Ruiz-del-Arbol L, et al (2004) Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 40: 793–801
Laine L, Planas R, Nevens F, Banares R, Patch D, Bosch J (2006) Treatment of the acute bleeding episode. In: De Franchis R (ed) Portal Hypertension IV: Proceedings of the Fourth Baveno International Consensus Workshop. Blackwell Publishing, Boston, pp217–242
Salerno F, Gerbes A, Gines P, Wong F, Arroyo V (2007) Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 56: 1310–1318
Ortega R, Gines P, Uriz J, et al (2002) Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, non randomised study. Hepatology 36: 941–948
VA/NIH Acute Renal Failure Trial Network (2008) Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359: 7–20
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Shawcross, D., Wendon, J. (2009). Acute-on-Chronic Liver Failure in Cirrhosis: Defining and Managing Organ Dysfunction. In: Vincent, JL. (eds) Intensive Care Medicine. Springer, New York, NY. https://doi.org/10.1007/978-0-387-92278-2_61
Download citation
DOI: https://doi.org/10.1007/978-0-387-92278-2_61
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-92277-5
Online ISBN: 978-0-387-92278-2
eBook Packages: MedicineMedicine (R0)